OUH - Ischemic heart disease

Ischemic Heart Disease

Academic interests

Prevention of reperfusion injury in myocardial infarction
Troponin - both molecular and clinical aspects
"FIRE"-trial: Chair of study in patients with myocardial infarction
EU-FP7, MITOCARE: Head of clinical trial consortium to study patients with myocardial infarction
Atrial fibrillation - pharmacotherapy

Information from Dan Atar's personal page at UiO

Recent publications

Agewall S (2019)
Old and new drugs in cardiovascular pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 5 (1), 1-2
DOI 10.1093/ehjcvp/pvy046, PubMed 30615170

Rutherford OW, Jonasson C, Ghanima W, Holst R, Halvorsen S (2018)
New score for assessing bleeding risk in patients with atrial fibrillation treated with NOACs
Open Heart, 5 (2), e000931
DOI 10.1136/openhrt-2018-000931, PubMed 30613418

Stubnova V, Os I, Høieggen A, Solbu MD, Grundtvig M, Westheim AS, Atar D, Waldum-Grevbo B (2019)
Gender differences in association between uric acid and all-cause mortality in patients with chronic heart failure
BMC Cardiovasc Disord, 19 (1), 4
DOI 10.1186/s12872-018-0989-8, PubMed 30611196

More publications